Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -20.740\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) CCC(=O)Nc1cccc(-c2cc3ccccc3oc2=O)c1
b.) COc1ccc(CNC(=O)CC(C)S(=O)(=O)c2ccc3c(c2)NC(=O)CO3)cc1
c.) NC(=O)c1ccc(NC(=O)c2cccc(Oc3ccccc3)c2)cc1
d.) COC(=O)c1ccc(CN2CCCC(C(=O)c3cc(F)ccc3OC)C2)cc1
Answer: a. CCC(=O)Nc1cccc(-c2cc3ccccc3oc2=O)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1cccc(-c2cc3ccccc3oc2=O)c1
CCC(=O)Nc1cccc(-c2cc3ccccc3oc2=O)c1
N-[3-(2-oxochromen-3-yl)phenyl]propanamide